Literature DB >> 6929785

The natural course of diabetic neuropathy. A follow-up.

A Bischoff.   

Abstract

Out of an unselected group of 160 patients with diabetic neuropathy 51 patients were followed up for an average of 5, 6 years by repeated neurological examinations and by means of a questionnaire. The control of the diabetes was requested from the house physicians. The patients were classified as presenting (1) a symmetrical, predominantly sensory neuropathy (2) a mixed syndrome with additional autonomic neuropathy and (3) multiple mononeuropathy. Individual symptoms and objective signs of neuropathy revealed a remarkable variety of changes. The outlook in multiple mononeuropathy and distal paresis was favorable while autonomic failures, in particular of male sexual function, progressed. There seemed to be some beneficial effect of improved glycemic control. However, despite satisfactory metabolic control some progression of diabetic neuropathy occured.

Entities:  

Mesh:

Year:  1980        PMID: 6929785

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  2 in total

1.  A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy.

Authors:  A J Boulton; S Levin; J Comstock
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

Review 2.  Clinical observations and experiments in diabetic neuropathy.

Authors:  P J Watkins
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.